$ADPT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adaptive Biotechnologies Corp. Get notifications about new insider transactions in Adaptive Biotechnologies Corp for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 10 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 49.00 | 15,275 | 748,475 | 0 | 15.3 K to 0 (-100.00 %) |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 0.84 | 15,275 | 12,831 | 15,275 | 0 to 15.3 K |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Option Exercise | M | 0.84 | 17,400 | 14,616 | 100,600 | |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 49.00 | 17,400 | 852,600 | 10,000 | 27.4 K to 10 K (-63.50 %) |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Buy | M | 0.84 | 17,400 | 14,616 | 27,400 | 10 K to 27.4 K (+174.00 %) |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 30,000 | 189,600 | 640,000 | |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 47.52 | 2,104 | 99,982 | 1,000 | 3.1 K to 1,000 (-67.78 %) |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 46.82 | 27,896 | 1,306,091 | 3,104 | 31 K to 3.1 K (-89.99 %) |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 30,000 | 189,600 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 0.84 | 15,275 | 12,831 | 94,725 | |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 49.00 | 15,275 | 748,475 | 0 | 15.3 K to 0 (-100.00 %) |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 0.84 | 15,275 | 12,831 | 15,275 | 0 to 15.3 K |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Option Exercise | M | 0.84 | 17,400 | 14,616 | 100,600 | |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 49.00 | 17,400 | 852,600 | 10,000 | 27.4 K to 10 K (-63.50 %) |
Jul 10 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Buy | M | 0.84 | 17,400 | 14,616 | 27,400 | 10 K to 27.4 K (+174.00 %) |
Jul 08 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Option Exercise | M | 6.32 | 10,000 | 63,200 | 55,000 | |
Jul 08 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 47.98 | 400 | 19,192 | 0 | 400 to 0 (-100.00 %) |
Jul 08 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 47.34 | 9,600 | 454,464 | 400 | 10 K to 400 (-96.00 %) |
Jul 08 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Buy | M | 6.32 | 10,000 | 63,200 | 10,000 | 0 to 10 K |
Jul 08 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Option Exercise | M | 7.80 | 6,250 | 48,750 | 437,500 | |
Jul 08 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 48.42 | 200 | 9,684 | 0 | 200 to 0 (-100.00 %) |
Jul 08 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 47.29 | 6,050 | 286,105 | 200 | 6.3 K to 200 (-96.80 %) |
Jul 08 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Buy | M | 7.80 | 6,250 | 48,750 | 6,250 | 0 to 6.3 K |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,563 | 11,363 | 46,875 | |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 70,313 | |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 41,667 | |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 48.13 | 1,200 | 57,756 | 0 | 1.2 K to 0 (-100.00 %) |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 47.17 | 5,571 | 262,784 | 1,200 | 6.8 K to 1.2 K (-82.28 %) |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,563 | 11,363 | 6,771 | 5.2 K to 6.8 K (+30.01 %) |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Option Exercise | M | 0.84 | 3,000 | 2,520 | 118,000 | |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 48.01 | 1,200 | 57,612 | 10,000 | 11.2 K to 10 K (-10.71 %) |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 47.03 | 1,800 | 84,654 | 11,200 | 13 K to 11.2 K (-13.85 %) |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Buy | M | 0.84 | 3,000 | 2,520 | 13,000 | 10 K to 13 K (+30.00 %) |
Jul 01 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.32 | 417 | 2,635 | 417 | |
Jul 01 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 47.42 | 417 | 19,774 | 0 | 417 to 0 (-100.00 %) |
Jul 01 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.32 | 417 | 2,635 | 417 | 0 to 417 |
Jun 30 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.32 | 417 | 2,635 | 417 | |
Jun 30 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 47.42 | 417 | 19,774 | 0 | 417 to 0 (-100.00 %) |
Jun 30 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.32 | 417 | 2,635 | 417 | 0 to 417 |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 400,200 | |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 411,300 | |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 422,400 | |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 47.25 | 3,743 | 176,857 | 679 | 4.4 K to 679 (-84.64 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.84 | 6,657 | 311,814 | 4,422 | 11.1 K to 4.4 K (-60.09 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 45.36 | 700 | 31,752 | 11,079 | 11.8 K to 11.1 K (-5.94 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.38 | 2,823 | 130,931 | 679 | 3.5 K to 679 (-80.61 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 45.72 | 8,277 | 378,424 | 3,502 | 11.8 K to 3.5 K (-70.27 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.95 | 9,600 | 450,720 | 679 | 10.3 K to 679 (-93.39 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.21 | 1,500 | 69,315 | 10,279 | 11.8 K to 10.3 K (-12.73 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 6.55 | 1,771 | 11,600 | 37,188 | |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 7.80 | 1,109 | 8,650 | 39,472 | |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 46.68 | 2,880 | 134,438 | 1,300 | 4.2 K to 1.3 K (-68.90 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 6.55 | 1,771 | 11,600 | 4,180 | 2.4 K to 4.2 K (+73.52 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 7.80 | 1,109 | 8,650 | 2,409 | 1.3 K to 2.4 K (+85.31 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 33,132 | 10,934 | 348,748 | |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.15 | 13,503 | 623,163 | 1,778,180 | 1.8 M to 1.8 M (-0.75 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.65 | 19,629 | 896,064 | 1,791,683 | 1.8 M to 1.8 M (-1.08 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 33,132 | 10,934 | 1,811,312 | 1.8 M to 1.8 M (+1.86 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 33,132 | 10,934 | 348,748 | |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.15 | 13,503 | 623,163 | 1,778,180 | 1.8 M to 1.8 M (-0.75 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.65 | 19,629 | 896,064 | 1,791,683 | 1.8 M to 1.8 M (-1.08 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 33,132 | 10,934 | 1,811,312 | 1.8 M to 1.8 M (+1.86 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Option Exercise | M | 0.84 | 19,000 | 15,960 | 121,000 | |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 45.38 | 14,694 | 666,814 | 10,000 | 24.7 K to 10 K (-59.50 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 44.66 | 4,306 | 192,306 | 24,694 | 29 K to 24.7 K (-14.85 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Buy | M | 0.84 | 19,000 | 15,960 | 29,000 | 10 K to 29 K (+190.00 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 4,167 | |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 45.00 | 417 | 18,765 | 0 | 417 to 0 (-100.00 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 24,560 | 8,105 | 381,880 | |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 406,440 | |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 28,440 | 9,385 | 423,120 | |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.52 | 400 | 18,208 | 1,778,180 | 1.8 M to 1.8 M (-0.02 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 44.91 | 24,160 | 1,085,026 | 1,778,580 | 1.8 M to 1.8 M (-1.34 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 24,560 | 8,105 | 1,802,740 | 1.8 M to 1.8 M (+1.38 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 44.41 | 16,680 | 740,759 | 1,778,180 | 1.8 M to 1.8 M (-0.93 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 44.38 | 28,040 | 1,244,415 | 1,778,180 | 1.8 M to 1.8 M (-1.55 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.76 | 400 | 17,504 | 1,806,220 | 1.8 M to 1.8 M (-0.02 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 28,440 | 9,385 | 1,806,620 | 1.8 M to 1.8 M (+1.60 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | M | 7.80 | 2,000 | 15,600 | 198,000 | |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 44.34 | 2,000 | 88,680 | 0 | 2 K to 0 (-100.00 %) |
Jun 19 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Buy | M | 7.80 | 2,000 | 15,600 | 2,000 | 0 to 2 K |
Jun 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 71,000 | |
Jun 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 43.42 | 984 | 42,725 | 0 | 984 to 0 (-100.00 %) |
Jun 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 42.59 | 1,016 | 43,271 | 984 | 2 K to 984 (-50.80 %) |
Jun 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Option Exercise | M | 7.80 | 4,167 | 32,503 | 443,750 | |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Option Exercise | M | 7.80 | 2,083 | 16,247 | 447,917 | |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 40.00 | 4,167 | 166,680 | 0 | 4.2 K to 0 (-100.00 %) |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Buy | M | 7.80 | 4,167 | 32,503 | 4,167 | 0 to 4.2 K |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 38.99 | 1,963 | 76,537 | 0 | 2 K to 0 (-100.00 %) |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 39.59 | 120 | 4,751 | 1,963 | 2.1 K to 2 K (-5.76 %) |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Buy | M | 7.80 | 2,083 | 16,247 | 2,083 | 0 to 2.1 K |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 8,750 | 55,300 | 670,000 | |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 21,250 | 134,300 | 678,750 | |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.00 | 8,750 | 350,000 | 1,000 | 9.8 K to 1,000 (-89.74 %) |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 8,750 | 55,300 | 9,750 | 1,000 to 9.8 K (+875.00 %) |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 39.80 | 2,445 | 97,311 | 1,000 | 3.4 K to 1,000 (-70.97 %) |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 38.99 | 18,805 | 733,207 | 3,445 | 22.3 K to 3.4 K (-84.52 %) |
Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 21,250 | 134,300 | 22,250 | 1,000 to 22.3 K (+2,125.00 %) |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Option Exercise | M | 6.32 | 5,000 | 31,600 | 65,000 | |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 39.79 | 5,000 | 198,950 | 0 | 5 K to 0 (-100.00 %) |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Buy | M | 6.32 | 5,000 | 31,600 | 5,000 | 0 to 5 K |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,562 | 11,356 | 48,438 | |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 72,917 | |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 43,271 | |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 40.00 | 6,770 | 270,800 | 0 | 6.8 K to 0 (-100.00 %) |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,562 | 11,356 | 6,770 | 5.2 K to 6.8 K (+29.99 %) |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
May 28 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 6.55 | 1,771 | 11,600 | 38,959 | |
May 28 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 7.80 | 1,109 | 8,650 | 40,581 | |
May 28 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 42.00 | 2,880 | 120,960 | 1,300 | 4.2 K to 1.3 K (-68.90 %) |
May 28 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 6.55 | 1,771 | 11,600 | 4,180 | 2.4 K to 4.2 K (+73.52 %) |
May 28 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 7.80 | 1,109 | 8,650 | 2,409 | 1.3 K to 2.4 K (+85.31 %) |
May 28 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.32 | 416 | 2,629 | 834 | |
May 28 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 42.00 | 416 | 17,472 | 0 | 416 to 0 (-100.00 %) |
May 28 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.32 | 416 | 2,629 | 416 | 0 to 416 |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 451,560 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 501,560 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 551,560 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Gift | G | 0.00 | 100,000 | 0 | 1,778,180 | 1.9 M to 1.8 M (-5.32 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 40.29 | 50,000 | 2,014,500 | 1,878,180 | 1.9 M to 1.9 M (-2.59 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 50,000 | 16,500 | 1,928,180 | 1.9 M to 1.9 M (+2.66 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 40.46 | 50,000 | 2,023,000 | 1,878,180 | 1.9 M to 1.9 M (-2.59 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 50,000 | 16,500 | 1,928,180 | 1.9 M to 1.9 M (+2.66 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 39.95 | 49,100 | 1,961,545 | 1,878,180 | 1.9 M to 1.9 M (-2.55 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 39.31 | 900 | 35,379 | 1,927,280 | 1.9 M to 1.9 M (-0.05 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 50,000 | 16,500 | 1,928,180 | 1.9 M to 1.9 M (+2.66 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 25,000 | 181,750 | 50,000 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 49,479 | 324,087 | 75,521 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 78,125 | 511,719 | 45,875 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 15,416 | 96,658 | 4,584 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 451,560 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.32 | 18,750 | 118,500 | 1,250 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 501,560 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 1.98 | 60,000 | 118,800 | 0 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 551,560 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 40.00 | 246,770 | 9,870,800 | 0 | 246.8 K to 0 (-100.00 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Gift | G | 0.00 | 100,000 | 0 | 1,778,180 | 1.9 M to 1.8 M (-5.32 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 25,000 | 181,750 | 246,770 | 221.8 K to 246.8 K (+11.27 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 40.29 | 50,000 | 2,014,500 | 1,878,180 | 1.9 M to 1.9 M (-2.59 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 49,479 | 324,087 | 221,770 | 172.3 K to 221.8 K (+28.72 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 50,000 | 16,500 | 1,928,180 | 1.9 M to 1.9 M (+2.66 %) |